Edward Phelps
AST DIR & ASO PROF
EG-BIOMEDICAL ENGINEERING
Orcid identifier0000-0001-8666-805X (opens in a new tab)
- AST DIR & ASO PROFEG-BIOMEDICAL ENGINEERING
GRANTS
- GRANTMicrogels for localized immune control in beta cell replacementNational Institute of Health Niddk6 Aug 2026 - 31 May 2031
- GRANTBeta Cell Impairment in T1D: Insights from Glucose Metabolism in Human Pancreas SlicesNational Institute of Health Niddk5 May 2026 - 30 Apr 2030
- GRANTLive human pancreas tissue slices as a platform for investigating the immunopathological processes of type 1 diabetesHelmsley Charitable Trust, Leona & Harry9 Apr 2026 - 30 Jun 2026
- GRANTIntegrated Islet Distribution Center- DTRSA- Integrating IIDP Human Islet Data to Investigate Beta Cell Dysfunction in DiabetesNational Institute of Health Niddk31 Jul 2025 - 31 Jul 2026
- GRANTImmunocore ImmTAAI technology and its potential use to treat type 1 diabetes autoimmunity.Immunocore Limited26 Jun 2024 - 31 Dec 2025
- GRANTTolerance signals from human pregnancy for beta cell replacement therapyBreakthrough T1d - Formerly Jdrf International1 Dec 2023 - 30 Nov 2025
- GRANTEngineered Nanocapsules for Targeted Drug Delivery to the ß-CellBreakthrough T1d - Formerly Jdrf International14 Jun 2023 - 31 Dec 2026
- GRANTImmune Function and the Progression to Type 1 DiabetesNational Institute of Health Niaid11 Apr 2023 - 31 May 2028
- GRANTCharacterization of Islet-derived Extracellular Vesicles for Improved Detection, Monitoring, Classification, and Treatment of Type 1 DiabetesNational Institute of Health Niddk15 Mar 2023 - 31 May 2027
- GRANTLocal immune modulation for beta cell replacement therapy in type 1 diabetesNational Institute of Health Niddk24 Mar 2022 - 31 Dec 2026
- GRANTThe role of GABA on pancreatic delta cells in health and type 1 diabetesDiabetes Research Connection11 Mar 2022 - 31 Jan 2023
- GRANTEngineering a Human Microphysiological System for the Characterization of Islet-Immune InteractionsNational Institute of Health Niddk10 Aug 2021 - 31 Jul 2025
- GRANTImmunocore ImmTAAI technology and its potential use to treat type 1 diabetes autoimmunityImmunocore Limited8 Mar 2021 - 28 Jul 2023
- GRANTMechanism and dynamics of islet GABA signalingNational Institute of Health Niddk11 Dec 2020 - 31 Dec 2026
- GRANTEngineered tolerogenic exosomes for treating type 1 diabetes autoimmunity20 Aug 2020 - 31 Dec 2022
- GRANTRegional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesisNational Institute of Health Niddk24 Jul 2020 - 30 Apr 2025
- GRANTEngineering a Human Microphysiological System for the Characterization of Islet-Immune InteractionsNational Institute of Health Niddk26 Jul 2019 - 31 Jul 2021
- GRANTTargeting the peri-islet basement membrane for immunomodulatory therapy in beta cell replacementBreakthrough T1D1 Jun 2019 - 1 Jan 2022People funded by this grant:
- Phelps EA
- GRANTTargeting the peri-islet basement membrane for immunomodulatory therapy in beta cell replacementBreakthrough T1d - Formerly Jdrf International29 Apr 2019 - 1 Jan 2022
- GRANTImmune Function and the Progression to Type 1 DiabetesNational Institute of Health Niaid20 Jun 2018 - 31 May 2023
- GRANTPathophysiology of GAD65 and GABA Signaling in Autoimmune DiabetesBreakthrough T1d - Formerly Jdrf International3 Mar 2017 - 28 Feb 2018
- GRANTPathophysiology of GAD65 and GABA Signaling in Autoimmune DiabetesBreakthrough T1D1 Mar 2017 - 28 Feb 2018People funded by this grant:
- Phelps EA
- GRANTImmune modulation of GAD65: enginering autoimmunity and tolerance in type 1 diabetesBreakthrough T1D1 May 2014 - 30 Apr 2017People funded by this grant:
- Phelps E
- GRANTSwiss National Science Foundation1 Apr 2011 - 31 Mar 2014People funded by this grant:
- Swartz M,
- Ballester M,
- Broggi M,
- Phelps EA,
- Pisano M